Benjamin Rawson, DO
Pain Medicine · Austin, TXNPI 1902889397
Payments from drug & device makers
Across 119 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$914
- Amgen$338
- Pacira Therapeutics, Inc.$216
- Biohaven Pharmaceutical Holding Company Ltd.$79
- Si-bone, Inc.$55
- Teleflex LLC$55
- plus $284 from 12 others
What the payments were for
- Food & beverage$1,941100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $914 |
| Amgen | 25 | $338 |
| Pacira Therapeutics, Inc. | 17 | $216 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $79 |
| Si-bone, Inc. | 2 | $55 |
| Teleflex LLC | 3 | $55 |
| Ultragenyx Pharmaceutical Inc. | 3 | $53 |
| Bioventus LLC | 1 | $33 |
| Relievant Medsystems, Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 2 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Medtronic | 1 | $17 |
| IBSA Pharma Inc. | 1 | $14 |
| Foundation Fusion Solutions, LLC | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
How this compares
$1,941 in reported general payments places this provider in the 35th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 12 | $8,074 |
| Celecoxib | 63 | $863 |
| Gabapentin | 40 | $362 |
| Pregabalin | 25 | $185 |
| Oxycodone Hcl | 13 | $178 |
| Methylprednisolone | 15 | $133 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $106 |
| Diclofenac Sodium | 25 | $85 |
| Cyclobenzaprine Hcl | 13 | $63 |
| Topiramate | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Austin
- Raj PatelAustin$120K
- Ramesh SingaAustin$34K
- Robert MousselliAustin$34K
- Sandford SchocketAustin$28K
- Mahan OstadianAustin$27K
- Raimy AmashaAustin$26K
- Matthew McCartyAustin$26K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.